75 related articles for article (PubMed ID: 3377855)
1. Intracellular drug concentration and DNA damage in human childhood leukemic cells exposed to doxorubicin.
Catapano CV; Ubezio P; Rossi V; Conter V; Jancovich M; D'Incalci M
Biochem Pharmacol; 1988 May; 37(9):1863-4. PubMed ID: 3377855
[No Abstract] [Full Text] [Related]
2. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
[TBL] [Abstract][Full Text] [Related]
3. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.
Bellamy WT; Dorr RT; Dalton WS; Alberts DS
Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055
[TBL] [Abstract][Full Text] [Related]
4. Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.
Maniar N; Krishan A; Israel M; Samy TS
Biochem Pharmacol; 1988 May; 37(9):1763-72. PubMed ID: 2837239
[TBL] [Abstract][Full Text] [Related]
5. Can cytotoxic activity of anthracyclines be related to DNA damage?
Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H
Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255
[TBL] [Abstract][Full Text] [Related]
6. Quinine circumvents the doxorubicin resistance of a multidrug resistant human leukemic cell-line, K562/DXR.
Solary E; Velay I; Chauffert B; Caillot D; Bidan JM; Dumas M; Casasnovas O; Guy H
Nouv Rev Fr Hematol (1978); 1990; 32(5):361-3. PubMed ID: 2099412
[TBL] [Abstract][Full Text] [Related]
7. Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells.
Szwed M; Jozwiak Z
Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():53-63. PubMed ID: 25308442
[TBL] [Abstract][Full Text] [Related]
8. Combination 6-mercaptopurine-adriamycin in refractory adult acute leukemia.
Rodriguez V; Bodey GP; McCredie KB; Freireich EJ; Minow RA; Casey JH; Luna M
Clin Pharmacol Ther; 1975 Oct; 18(4):462-6. PubMed ID: 1100309
[TBL] [Abstract][Full Text] [Related]
9. Alteration of binding of the supravital dye Hoechst 33342 to human leukemic cells by adriamycin.
Preisler HD
Cancer Treat Rep; 1978 Sep; 62(9):1393-6. PubMed ID: 688284
[No Abstract] [Full Text] [Related]
10. Editorial: Adriamycin and the heart.
Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
[No Abstract] [Full Text] [Related]
11. Combined effect of lipoic acid and doxorubicin in murine leukemia.
Dovinová I; Novotný L; Rauko P; Kvasnicka P
Neoplasma; 1999; 46(4):237-41. PubMed ID: 10613604
[TBL] [Abstract][Full Text] [Related]
12. Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leukemia cells.
Ganapathi R; Kamath N; Constantinou A; Grabowski D; Ford J; Anderson A
Biochem Pharmacol; 1991 Jun; 41(12):R21-6. PubMed ID: 1674871
[TBL] [Abstract][Full Text] [Related]
13. Temperature dependence of adriamycin-induced DNA damage in L1210 cells.
Vichi P; Robison S; Tritton TR
Cancer Res; 1989 Oct; 49(20):5575-80. PubMed ID: 2551489
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of K562 Leukemia Cells to Doxorubicin by the Viscum album Extract.
Srdic-Rajic T; Tisma-Miletic N; Cavic M; Kanjer K; Savikin K; Galun D; Konic-Ristic A; Zoranovic T
Phytother Res; 2016 Mar; 30(3):485-95. PubMed ID: 26692465
[TBL] [Abstract][Full Text] [Related]
15. Effect of schisanhenol on the antitumor activity of adriamycin.
Lin TJ; Liu GT
Biochem Biophys Res Commun; 1991 Jul; 178(1):207-12. PubMed ID: 2069560
[TBL] [Abstract][Full Text] [Related]
16. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F
Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645
[TBL] [Abstract][Full Text] [Related]
17. Effect of concentration on the cytotoxic mechanism of doxorubicin--apoptosis and oxidative DNA damage.
Müller I; Jenner A; Bruchelt G; Niethammer D; Halliwell B
Biochem Biophys Res Commun; 1997 Jan; 230(2):254-7. PubMed ID: 9016760
[TBL] [Abstract][Full Text] [Related]
18. Remission-induction, consolidation and maintenance therapy by AVA protocol in acute nonlymphoblastic leukemia.
Torlontano G; Geraci L; Lombardo M; Di Marzio A; Iacone A; Fioritoni G; Bonanni G; Di Bartolomeo P; Ballone E; D'Antonio D; Di Girolamo G; D'Arcangelo L; Pandoli G; Natale D; Spadano A
Haematologica; 1982 Apr; 67(2):230-45. PubMed ID: 6807770
[No Abstract] [Full Text] [Related]
19. [Comparative accumulation of the Hoechst 33258 fluorescent probe in leukemia P388 cells sensitive and resistant to doxorubicin].
Donenko FV; Borovkova NB; Egudina SV; Kabieva AO; Kris'ko ShI; Moroz LV
Biull Eksp Biol Med; 1990 Sep; 110(9):310-2. PubMed ID: 2268726
[TBL] [Abstract][Full Text] [Related]
20. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS
Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
